Anisotropic Nanoparticle Shear Sensing for Cell Behavior Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying cell sample behavior, particularly ciliary beating and mucociliary clearance, are slow, costly, and difficult to implement in clinical settings, with existing techniques lacking sufficient resolution and being invasive or time-consuming.
Innovation Solution
A process using anisotropically-shaped nanoparticles dispersed in a fluid medium to determine shear characteristics and cell sample properties by measuring nanoparticle orientation, allowing for efficient evaluation of ciliary beating efficiency through photoluminescent and birefringent properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If high-resolution optical or electron microscopy tools are used to study cell behavior, then measurement precision is improved, but device complexity and cost increase
Solution Approach 1:
The patent introduces anisotropically-shaped nanoparticles as an intermediary medium between the light source and the cell sample. These nanoparticles serve as flow-sensitive indicators that translate fluid motion into optical signals, enabling measurement of cell-induced fluid flow without requiring complex microscopy systems. The nanoparticles mediate the interaction between light and the fluid dynamics, simplifying the overall measurement apparatus.
Solution Approach 2:
The patent replaces complex mechanical microscopy systems with an optical-based particle tracking approach. Instead of using high-resolution optical or electron microscopy tools combined with complex image analysis, the invention uses the optical properties of anisotropically-shaped nanoparticles to directly visualize and measure fluid flow patterns induced by cell activities, substituting mechanical complexity with optical simplicity.
2Measurement precision
If high-resolution optical or electron microscopy tools combined with complex image analysis are used, then measurement precision is improved, but productivity decreases
Solution Approach 1:
The patent replaces time-consuming complex image analysis procedures with direct optical observation of nanoparticle orientation and movement. The anisotropically-shaped nanoparticles provide visually detectable signals that can be analyzed through simpler optical methods, eliminating the need for lengthy image processing and interpretation steps while maintaining measurement accuracy.
Solution Approach 2:
The anisotropically-shaped nanoparticles serve as self-indicating flow tracers that automatically reveal fluid motion patterns through their orientation and movement. The particles themselves provide the measurement signal without requiring external complex analysis systems, enabling rapid assessment of cell-induced fluid flow and improving productivity.
3Productivity
If particle imaging velocimetry is used to track micro-bead motion, then productivity is improved, but measurement precision deteriorates
Solution Approach 1:
The patent employs anisotropically-shaped nanoparticles with asymmetric geometries (such as rods, ellipsoids, or platelets) instead of spherical micro-beads. This asymmetry provides inherent orientation information that enhances measurement precision, as the particles' alignment with flow direction can be directly observed and measured, offering more detailed fluid dynamics data than isotropic spherical particles.
Solution Approach 2:
The anisotropically-shaped nanoparticles exhibit orientation-dependent optical properties, including changes in light scattering, absorption, or fluorescence intensity based on their alignment. This optical anisotropy provides enhanced measurement precision by allowing direct visualization of particle orientation and flow direction, transforming mechanical flow information into optical signals that improve measurement accuracy.
4Measurement precision
If in vivo evaluation techniques such as saccharin test or radioactive tracer clearance are used, then measurement precision is improved, but ease of operation deteriorates
Solution Approach 1:
The patent uses non-toxic, biocompatible anisotropically-shaped nanoparticles as disposable flow indicators that can be easily introduced into the system and then discarded after measurement. These nanoparticles replace expensive and complex radioactive tracers or saccharin solutions, providing a simple, inexpensive, and easily operable alternative that maintains measurement precision without requiring specialized handling procedures.
Solution Approach 2:
The anisotropically-shaped nanoparticles serve as a safe intermediary substance that mediates the measurement process without requiring patient cooperation or invasive procedures. Unlike saccharin tests requiring patient participation or radioactive tracers requiring special safety protocols, these nanoparticles provide a straightforward, easy-to-operate measurement system that maintains precision while simplifying the operational procedure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a fast, cost-effective, and clinically suitable means to assess cell sample behavior with high spatial and temporal resolution, enabling efficient characterization of ciliary beating efficiency.
Implementation Method 1
determining a shear characteristic of the fluid medium in the measurement zone from the nanoparticle orientation characteristic determined in this measurement zone
Implementation Method 2
The nanoparticles are configured to emit photoluminescent radiation
Implementation Method 3
The nanoparticles exhibit polarized photoluminescence emission
Data Source
AI summary
A method for studying the behaviour of a cell sample contained in a medium containing a plurality of anisotropically shaped nanoparticles dispersed therein, the method including: (i) determining at least one nanoparticle orientation characteristic in a measurement zone at the interface between the fluid medium and the cell sample, the orientation resulting at least partially from the interaction of the fluid medium and the biological material; (ii) determining a mean shear rate characteristic of the fluid medium in the measurement zone from said at least one nanoparticle orientation characteristic determined in this measurement zone; and (iii) determining a characteristic of the cell sample from the mean shear rate thus determined in the measurement zone.